ARMP earnings: a positive outcome, +7.9%

On November 12, 2020, Armata Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +7.9% in the window around the event. It had already run +11.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.